Stocks and InvestingStocks and Investing
Fri, June 2, 2023
Thu, June 1, 2023

Kevin Steinke Maintained (CCRN) at Buy with Decreased Target to $35 on, Jun 1st, 2023


Published on 2024-10-28 04:08:08 - WOPRAI, Kevin Steinke
  Print publication without navigation


Kevin Steinke of Barrington Research, Maintained "Cross Country Healthcare, Inc." (CCRN) at Buy with Decreased Target from $42 to $35 on, Jun 1st, 2023.

Kevin has made no other calls on CCRN in the last 4 months.



There are 5 other peers that have a rating on CCRN. Out of the 5 peers that are also analyzing CCRN, 3 agree with Kevin's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Jonathan Yong of "Credit Suisse" Maintained at Hold with Decreased Target to $27 on, Friday, May 5th, 2023
  • Tobey Sommer of "Truist Securities" Maintained at Hold with Decreased Target to $25 on, Tuesday, May 2nd, 2023
  • Jonathan Yon of "Credit Suisse" Maintained at Hold with Increased Target to $32 on, Thursday, February 23rd, 2023


These are the ratings of the 2 analyists that currently disagree with Kevin


  • Joseph France of "Loop Capital" Initiated at Strong Buy and Held Target at $30 on, Friday, March 10th, 2023
  • Bill Sutherland of "Benchmark" Maintained at Strong Buy with Decreased Target to $40 on, Thursday, February 23rd, 2023